Asymmetric activation of the calcium-sensing receptor homodimer

<p>The calcium-sensing receptor (CaSR), a cell-surface sensor for Ca<sup>2+</sup>, is the master regulator of calcium homeostasis in humans and is the target of calcimimetic drugs for the treatment of parathyroid disorders<sup>1</sup>. CaSR is a family C G-protein-coupl...

Full description

Bibliographic Details
Main Authors: Gao, Y, Robertson, MJ, Rahman, SN, Seven, AB, Zhang, C, Meyerowitz, JG, Panova, O, Hannan, FM, Thakker, RV, Bräuner-Osborne, H, Mathiesen, JM, Skiniotis, G
Format: Journal article
Language:English
Published: Springer Nature 2021
Description
Summary:<p>The calcium-sensing receptor (CaSR), a cell-surface sensor for Ca<sup>2+</sup>, is the master regulator of calcium homeostasis in humans and is the target of calcimimetic drugs for the treatment of parathyroid disorders<sup>1</sup>. CaSR is a family C G-protein-coupled receptor<sup>2</sup>&nbsp;that functions as an obligate homodimer, with each protomer composed of a Ca<sup>2+</sup>-binding extracellular domain and a seven-transmembrane-helix domain (7TM) that activates heterotrimeric G proteins. Here we present cryo-electron microscopy structures of near-full-length human CaSR in inactive or active states bound to Ca<sup>2+</sup>&nbsp;and various calcilytic or calcimimetic drug molecules. We show that, upon activation, the CaSR homodimer adopts an asymmetric 7TM configuration that primes one protomer for G-protein coupling. This asymmetry is stabilized by 7TM-targeting calcimimetic drugs adopting distinctly different poses in the two protomers, whereas the binding of a calcilytic drug locks CaSR 7TMs in an inactive symmetric configuration. These results provide a detailed structural framework for CaSR activation and the rational design of therapeutics targeting this receptor.</p>